Oligomerization of the human prion protein proceeds via a molten globule intermediate

Remo Gerber1, Abdessamad Tahiri-Alaoui, P J Hore

  • 1Department of Chemistry, University of Oxford, Physical and Theoretical Chemistry Laboratory, South Parks Road, Oxford OX1 3QZ, United Kingdom. remo.gerber@chem.ox.ac.uk

Insights

Prion protein misfolding, crucial in disease, does not start with beta-sheet structures. Instead, an alpha-helical precursor with molten globule traits initiates the conversion to beta-oligomers.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Neuroscience

Background:

  • Prion diseases involve the human prion protein (PrP) misfolding from alpha-helical to beta-sheet structures.
  • The exact molecular mechanisms and intermediate states of PrP misfolding are not well understood.
  • Amyloid fibrils, characteristic of prion diseases, are insoluble, hindering detailed study.

Purpose of the Study:

  • To investigate the misfolding mechanism of the human prion protein (PrP).
  • To characterize the structural properties of the beta-oligomer, a misfolded PrP isoform.
  • To identify the nature of the precursor state in PrP misfolding.

Main Methods:

  • Solution-state Nuclear Magnetic Resonance (NMR) spectroscopy was employed.
  • The study focused on the beta-oligomer, a partially proteinase-resistant misfolded PrP isoform.
  • Analysis of the transient monomeric precursor state was performed.

Main Results:

  • The beta-oligomer, sharing properties with amyloid, was successfully studied using solution-state NMR.
  • Evidence was found for an alpha-helical, molten globule-like monomeric precursor, not a beta-sheet precursor.
  • A mechanism involving intermolecular contacts triggering beta-oligomer formation was proposed.

Conclusions:

  • The human prion protein beta-oligomer forms from an alpha-helical precursor, not a beta-sheet precursor.
  • Misfolding is initiated by a partially unfolded, alpha-helical state with molten globule characteristics.
  • This finding challenges previous assumptions about prion protein misfolding pathways.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
Post-translational Translocation of Proteins to the RER01:27

Post-translational Translocation of Proteins to the RER

A sizable fraction of proteins destined for ER are first synthesized in the cell cytosol and then transported across the ER membrane–a process called post-translational translocation. Similar to cotranslationally translocated proteins, these proteins also use the Sec translocon complex to enter the ER lumen.
Targeting proteins to the ER
Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...
Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
Protein Folding01:22

Protein Folding

Overview